These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Dalal D, Molin LH, Piccini J, Tichnell C, James C, Bomma C, Prakasa K, Towbin JA, Marcus FI, Spevak PJ, Bluemke DA, Abraham T, Russell SD, Calkins H, Judge DP. Circulation; 2006 Apr 04; 113(13):1641-9. PubMed ID: 16549640 [Abstract] [Full Text] [Related]
3. Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Qiu X, Liu W, Hu D, Zhu T, Li C, Li L, Guo C, Liu X, Wang L, Zheng H, Wang C, Diao Q, Shi D, Zhan P, Deng Y, Liu K, Wang Y, Liu B, Liu H, Zhang L. Am J Cardiol; 2009 May 15; 103(10):1439-44. PubMed ID: 19427443 [Abstract] [Full Text] [Related]
4. Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter study. Bhuiyan ZA, Jongbloed JD, van der Smagt J, Lombardi PM, Wiesfeld AC, Nelen M, Schouten M, Jongbloed R, Cox MG, van Wolferen M, Rodriguez LM, van Gelder IC, Bikker H, Suurmeijer AJ, van den Berg MP, Mannens MM, Hauer RN, Wilde AA, van Tintelen JP. Circ Cardiovasc Genet; 2009 Oct 15; 2(5):418-27. PubMed ID: 20031616 [Abstract] [Full Text] [Related]
8. Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis. Antoniades L, Tsatsopoulou A, Anastasakis A, Syrris P, Asimaki A, Panagiotakos D, Zambartas C, Stefanadis C, McKenna WJ, Protonotarios N. Eur Heart J; 2006 Sep 15; 27(18):2208-16. PubMed ID: 16893920 [Abstract] [Full Text] [Related]
10. Clinical and genetic characterization of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy caused by a plakophilin-2 splice mutation. van der Smagt JJ, van der Zwaag PA, van Tintelen JP, Cox MG, Wilde AA, van Langen IM, Ummels A, Hennekam FA, Dooijes D, Gerbens F, Bikker H, Hauer RN, Doevendans PA. Cardiology; 2012 Sep 15; 123(3):181-9. PubMed ID: 23147395 [Abstract] [Full Text] [Related]
11. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family. Kannankeril PJ, Bhuiyan ZA, Darbar D, Mannens MM, Wilde AA, Roden DM. Heart Rhythm; 2006 Aug 15; 3(8):939-44. PubMed ID: 16876743 [Abstract] [Full Text] [Related]
13. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Bourfiss M, Te Riele AS, Mast TP, Cramer MJ, VAN DER Heijden JF, VAN Veen TA, Loh P, Dooijes D, Hauer RN, Velthuis BK. J Cardiovasc Electrophysiol; 2016 Dec 15; 27(12):1420-1428. PubMed ID: 27572111 [Abstract] [Full Text] [Related]
16. Familial form of arrhythmogenic right ventricular cardiomyopathy. Włodarska EK, Konka M, Kepski R, Zaleska T, Płoski R, Ruzyłło W, Janion M, Jaworska K, Rydlewska-Sadowska W, Hoffman P. Kardiol Pol; 2004 Jan 15; 60(1):1-14. PubMed ID: 15004627 [Abstract] [Full Text] [Related]
17. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. Bhonsale A, Groeneweg JA, James CA, Dooijes D, Tichnell C, Jongbloed JD, Murray B, te Riele AS, van den Berg MP, Bikker H, Atsma DE, de Groot NM, Houweling AC, van der Heijden JF, Russell SD, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Calkins H, Hauer RN. Eur Heart J; 2015 Apr 07; 36(14):847-55. PubMed ID: 25616645 [Abstract] [Full Text] [Related]
18. Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. Smith W, Members of CSANZ Cardiovascular Genetics Working Group. Heart Lung Circ; 2011 Dec 07; 20(12):757-60. PubMed ID: 21885338 [Abstract] [Full Text] [Related]
19. Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Fressart V, Duthoit G, Donal E, Probst V, Deharo JC, Chevalier P, Klug D, Dubourg O, Delacretaz E, Cosnay P, Scanu P, Extramiana F, Keller D, Hidden-Lucet F, Simon F, Bessirard V, Roux-Buisson N, Hebert JL, Azarine A, Casset-Senon D, Rouzet F, Lecarpentier Y, Fontaine G, Coirault C, Frank R, Hainque B, Charron P. Europace; 2010 Jun 07; 12(6):861-8. PubMed ID: 20400443 [Abstract] [Full Text] [Related]
20. Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers. Groeneweg JA, van der Zwaag PA, Olde Nordkamp LR, Bikker H, Jongbloed JD, Jongbloed R, Wiesfeld AC, Cox MG, van der Heijden JF, Atsma DE, de Boer K, Doevendans PA, Vink A, van Veen TA, Dooijes D, van den Berg MP, Wilde AA, van Tintelen JP, Hauer RN. Am J Cardiol; 2013 Oct 15; 112(8):1197-206. PubMed ID: 23871674 [Abstract] [Full Text] [Related] Page: [Next] [New Search]